業績

英語論文
English Articles

  • Association of filaggrin gene mutations and childhood eczema and wheeze with phthalates and phosphorus flame retardants in house dust: The Hokkaido study on Environment and Children’s Health.
    Ait Bamai Y, Araki A, Nomura T, Kawai T, Tsuboi T, Kobayashi S, Miyashita C, Takeda M, Shimizu H, Kishi R
    Environ Int 121: 102-110, 2018.
  • Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.
    Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Furudate S, Hidaka T, Aiba S
    Oncotarget 9: 15542-15551, 2018.
  • Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma.
    Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Wada N, Irie H, Hidaka T, Hashimoto A, Aiba S
    Front Oncol 8: 530, 2018.
  • Acute vascular reaction due to lipo-prostaglandin E1.
    Fujimura Y, Watanabe M, Natsuga K, Shimizu H
    J Eur Acad Dermatol Venereol 32: e273-e274, 2018.
  • Baseline neutrophil to lymphocyte ratio combined with serum lactate dehydrogenase level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.
    Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Fujimura T, Yamamoto Y, Hata H, Tanaka R, Yamaguchi K, Nonomura Y, Hirai I, Furudate S, Okuhira H, Imafuku K, Aoki M, Matsushita S
    Br J Dermatol 179: 213-215, 2018.
  • Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients.
    Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Uchi H, Fujimura T, Matsushita S, Hata H, Okuhira H, Tanaka R, Nagai K, Ishida Y, Nakamura Y, Furudate S, Yamamura K, Imafuku K, Yamamoto Y
    J Dermatol Sci 89: 60-66, 2018.
  • Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.
    Han N, Baghdadi M, Ishikawa K, Endo H, Kobayashi T, Wada H, Imafuku K, Hata H, Seino KI
    Inflamm Regen 38: 3, 2018.
  • Case of anti-p200 pemphigoid accompanying uterine malignancy.
    Hayashi M, Okamura K, Ujiie H, Iwata H, Suzuki T
    J Dermatol 45: e341-e342, 2018.
  • Protein kinase C-dependent cell damage by unsaturated carbonyl compounds in vascular cells.
    Higashi T, Mai Y, Mazaki Y
    J Biosci Bioeng 126: 527-532, 2018.
  • Assessment of the methods used to detect HER2-positive advanced extramammary Paget’s disease.
    Hirai I, Tanese K, Nakamura Y, Otsuka A, Fujisawa Y, Yamamoto Y, Hata H, Fujimura T, Matsushita S, Yoshino K, Kameyama K, Amagai M, Funakoshi T
    Med Oncol 35: 92, 2018.
  • Rapid response to clinical symptoms in early psoriatic onycho-pachydermo-periostitis treated with infliximab.
    Horie K, Fujita Y, Hoshina D, Abe R, Shimizu H
    Australas J Dermatol 59: e78-e79, 2018.
  • Paradoxical localized exacerbation of psoriatic eruptions triggered by secukinumab.
    Hoshina D, Haga N, Furuya K, Sakai M
    Clin Exp Dermatol 43: 718-719, 2018.
  • Case of successfully switching from nivolumab to vemurafenib with oral corticosteroids.
    Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H
    J Dermatol 45: e156, 2018.
  • Potential role of extracellular vesicle-mediated antigen presentation in Helicobacter pylori hypersensitivity during eradication therapy.
    Ito T, Shiromizu T, Ohnishi S, Suzuki S, Mabe K, Hasegawa A, Ujiie H, Fujita Y, Sato Y, Terai S, Kato M, Asaka M, Tomonaga T, Shimizu H, Abe R
    J Allergy Clin Immunol 142: 672-676.e612, 2018.
  • Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients.
    Iwata H, Vorobyev A, Koga H, Recke A, Zillikens D, Prost-Squarcioni C, Ishii N, Hashimoto T, Ludwig RJ
    Orphanet J Rare Dis 13: 153, 2018.
  • Case of bullous pemphigoid associated with teneligliptin accompanied by severe mucous membrane involvement.
    Kage Y, Yamaguchi Y, Uchida T, Izumi K, Nishie W, Shimizu H, Ishii N, Hashimoto T, Aihara M
    J Dermatol 45: e205-e206, 2018.
  • Oral mucosa is a useful substrate for detecting autoantibodies of mucous membrane pemphigoid.
    Kamaguchi M, Iwata H, Ujiie H, Izumi K, Natsuga K, Nishie W, Asaka T, Kitagawa Y, Shimizu H
    Br J Dermatol 178: e119-e121, 2018.
  • High expression of collagen XVII compensates for its depletion induced by pemphigoid IgG in the oral mucosa.
    Kamaguchi M, Iwata H, Ujiie H, Natsuga K, Nishie W, Kitagawa Y, Shimizu H
    J Invest Dermatol 138: 1707-1715, 2018.
  • Mucosal substrates successfully identify the autoantigen in a case of mucous membrane pemphigoid.
    Kamaguchi M, Iwata H, Ujiie H, Ohga N, Kitagawa Y, Shimizu H
    J Dtsch Dermatol Ges 16: 1032-1034, 2018.
  • Direct Immunofluorescence Using Non-Lesional Buccal Mucosa in Mucous Membrane Pemphigoid.
    Kamaguchi M, Iwata H, Ujiie I, Ujiie H, Sato J, Kitagawa Y, Shimizu H
    Front Med (Lausanne) 5: 20, 2018.
  • Lipofuscin deposition causes the pigmentation of apocrine hidrocystoma.
    Kitamura S, Yanagi T, Imafuku K, Hata H, Shimizu H
    J Dermatol 45: 91-94, 2018.
  • Dermoscopic evaluation for skin grafts after surgery; neo-vascularization correlates with survival of skin grafts: A prospective study.
    Kitamura S, Yanagi T, Inamura-Takashima Y, Imafuku K, Hata H, Fujioka Y, Ohba Y, Shimizu H
    J Dermatol Sci 90: 213-216, 2018.
  • Retrospective study on the correlation between 18-fluorodeoxyglucose uptake in positron emission tomography-computer tomography and tumour volume, cytological activity as assessed with Ki-67 and GLUT-1 staining in 10 cases of Merkel cell carcinoma.
    Kitamura S, Yanagi T, Inamura-Takashima Y, Imafuku K, Hata H, Uehara J, Ishida Y, Otsuka A, Hirata K, Shimizu H
    J Eur Acad Dermatol Venereol 32: e285-e287, 2018.
  • Interplay between epidermal stem cell dynamics and dermal deformation.
    Kobayashi Y, Yasugahira Y, Kitahata H, Watanabe M, Natsuga K, Nagayama M
    NPJ comput mater 4: 1-9, 2018.
  • Filaggrin gene mutations may influence the persistence of food allergies in Japanese primary school children.
    Kono M, Akiyama M, Inoue Y, Nomura T, Hata A, Okamoto Y, Takeichi T, Muro Y, McLean WHI, Shimizu H, Sugiura K, Suzuki Y, Shimojo N
    Br J Dermatol 179: 190-191, 2018.
  • A 76-year-old woman returning from Venezuela with unusual eruptions on the feet.
    Kosumi H, Iwata H, Miyazawa H, Tsujiwaki M, Mai Y, Ando S, Ito T, Yamano K, Shimizu H
    Clin Infect Dis 66: 1973-1974, 2018.
  • Dermoscopic features of tungiasis.
    Kosumi H, Iwata H, Miyazawa H, Tsujiwaki M, Mai Y, Ando S, Ito T, Yamano K, Shimizu H
    J Eur Acad Dermatol Venereol 32: e313-e314, 2018.
  • Diagnosis at a Glance: Acquired Perforating Dermatosis.
    Kosumi H, Iwata H, Tsujiwaki M, Shimizu H
    Diabetes Care 41: 911-912, 2018.
  • Diagnostic features of acquired dermal melanocytosis of the face and extremities.
    Kosumi H, Miyauchi T, Nomura T, Suzuki S, Ohguchi Y, Nomura A, Shimizu H
    Clin Exp Dermatol 43: 806-809, 2018.
  • Ramucirumab-induced multiple haemangiomas of the skin: Two case reports.
    Kosumi H, Nishie W, Sugai T, Toyonaga E, Yoshimoto N, Nakamura H, Horibe R, Kitamura Y, Nakatsumi H, Shimizu H
    Acta Derm Venereol 98: 454-455, 2018.
  • Sweet’s syndrome mimicking anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Kosumi H, Watanabe M, Natsuga K, Miyauchi T, Shiiya C, Ujiie H, Shimizu H
    Am J Med 131: e241-e242, 2018.
  • Unusual post-patch testing erythema: a late, granulomatous, non-eczematous reaction to gold sodium thiosulphate.
    Kosumi H, Yanagi T, Izumi K, Ito T, Shimizu H
    J Eur Acad Dermatol Venereol 32: e126-e127, 2018.
  • Horn-like tumour on the dorsal hand.
    Kosumi H, Yanagi T, Maeda T, Sugai T, Imafuku K, Hata H, Shimizu H
    Lancet Infect Dis 18: 696, 2018.
  • Extensive eruptive syringoma after liver transplantation.
    Maeda T, Natsuga K, Nishie W, Yamashita K, Shimizu H
    Acta Derm Venereol 98: 119-120, 2018.
  • Dermoscopic features of Bednar tumor: Report of a case.
    Maeda T, Watabe Y, Yanagi T, Imafuku K, Kitamura S, Hata H, Nomura T, Shimizu H
    J Dermatol 45: e179-e180, 2018.
  • Successful outcome of early ambulation after extensive skin grafting in extramammary Paget’s disease.
    Maeda T, Yoshino K, Nagai K, Oaku S, Kato M, Hata H
    J Dermatol 45: 1456-1458, 2018.
  • Apocrine mixed tumour on the abdomen: an atypical location.
    Mai S, Fujita Y, Sugai T, Imafuku K, Hata H, Shinkuma S, Nomura T, Kawagishi N, Shimizu H
    Eur J Dermatol 28: 234-235, 2018.
  • Remission of cutaneous involvement in splenic marginal zone lymphoma after splenectomy.
    Mai S, Natsuga K, Shiratori S, Takahashi Y, Shimizu H
    Acta Derm Venereol 98: 801-802, 2018.
  • Detection of anti-BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid: a report of three patients.
    Mai Y, Nishie W, Izumi K, Yoshimoto N, Morita Y, Watanabe M, Toyonaga E, Ujiie H, Iwata H, Fujita Y, Nomura T, Sato-Matsumura KC, Shimizu S, Shimizu H
    Br J Dermatol 179: 790-791, 2018.
  • Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.
    Mai Y, Nishie W, Sato K, Hotta M, Izumi K, Ito K, Hosokawa K, Shimizu H
    Front Immunol 9: 542, 2018.
  • Six-month History of a Split Thumbnail: A Quiz.
    Mai Y, Ujiie H, Anan T, Miyazawa H, Imafuku K, Hamasaka K, Shimizu H
    Acta Derm Venereol 98: 297-298, 2018.
  • A case of red lunulae after haematopoietic stem cell transplantation.
    Mai Y, Ujiie H, Iguchi A, Shimizu H
    Eur J Dermatol 28: 407-409, 2018.
  • Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis.
    Maki N, Nishie W, Takazawa M, Kakurai M, Yamada T, Umemoto N, Kawase M, Izumi K, Shimizu H, Demitsu T
    J Dermatol 45: 600-602, 2018.
  • Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes.
    Matsumura W, Fujita Y, Nakayama C, Shinkuma S, Suzuki S, Nomura T, Abe R, Shimizu H
    J Dermatol Sci 89: 263-271, 2018.
  • A refractory cutaneous abscess.
    Maya Y, Narasaki W, Maeda Y, Ota M
    Am J Med 131: e259-e260, 2018.
  • Drug-induced localised scleroderma.
    Maya Y, Ota M
    BMJ 361: k1326, 2018.
  • Persistent red and swollen eyelids.
    Maya Y, Tashimo A, Ota M
    Lancet 392: 1552, 2018.
  • Two cases of generalized pustular psoriasis complicated by IgG4-related disease.
    Miyazawa H, Fujita Y, Iwata H, Ishikawa Y, Nishio S, Ishijima K, Shinmei Y, Takeichi T, Goto K, Oi R, Akiyama M, Shimizu H
    Br J Dermatol 179: 537-539, 2018.
  • A severe case of mango dermatitis.
    Miyazawa H, Nishie W, Hata H, Matsumura K, Shimizu H
    J Eur Acad Dermatol Venereol 32: e160-e161, 2018.
  • A solitary reddish nodule on the lower leg.
    Miyazawa H, Shinkuma S, Yamaguchi Y, Fujita Y, Nomura T, Shimizu H
    Int J Dermatol 57: 276-277, 2018.
  • Linagliptin treatment-associated bullous pemphigoid presenting severe mucosal erosions.
    Mukaijo J, Kanaoka M, Kawano K, Matsukura S, Hibiya T, Miyake A, Izumi K, Nishie W, Shimizu H, Aihara M
    Journal of Cutan Immunol Allergy 1: 77-78, 2018.
  • Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects.
    Muramatsu K, Ujiie H, Kobayashi I, Nishie W, Izumi K, Ito T, Yoshimoto N, Natsuga K, Iwata H, Shimizu H
    J Allergy Clin Immunol 142: 1818-1830.e1816, 2018.
  • Simultaneous development of cutaneous vasculitis and an autoimmune bullous skin disease during anti-TNF therapy for rheumatoid arthritis: a case report and review of the literature.
    Nakamura Y, Ohmura K, Dainichi T, Kuramoto N, Takeuchi Y, Akizuki S, Murakami K, Nakashima R, Yoshifuji H, Nishie W, Izumi K, Shimizu H, Hashimoto M, Tanaka M, Sakurai T, Kitoh A, Mimori T
    Modern Rheumatology Case Reports 2: 130-136, 2018.
  • The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
    Nakayama C, Fujita Y, Matsumura W, Ujiie I, Takashima S, Shinkuma S, Nomura T, Abe R, Shimizu H
    J Dermatol Sci 91: 301-310, 2018.
  • Dyshidrosiform palmoplantar pemphigoid with low-titer autoantibodies against BP180 NC16A.
    Nakazawa S, Izumi K, Nishie W, Shimizu H, Tokura Y
    Journal of Cutan Immunol Allergy 1: 27-30, 2018.
  • Chromosomal inversions as a hidden disease-modifying factor for somatic recombination phenotypes.
    Nomura T, Suzuki S, Miyauchi T, Takeda M, Shinkuma S, Fujita Y, Nishie W, Akiyama M, Shimizu H
    JCI Insight 3: e97595, 2018.
  • Gentamicin-induced readthrough and nonsense-mediated mRNA decay of SERPINB7 nonsense transcripts.
    Ohguchi Y, Nomura T, Suzuki S, Takeda M, Miyauchi T, Mizuno O, Shinkuma S, Fujita Y, Nemoto O, Ono K, McLean WHI, Shimizu H
    J Invest Dermatol 138: 836-843, 2018.
  • Disseminated fusariosis emerged from prolonged local genital infection after cord blood transplantation.
    Okada K, Endo T, Hashimoto D, Saga T, Ara T, Ogasawara R, Yasumoto A, Ibata M, Takahata M, Shigematsu A, Kondo T, Muraosa Y, Nomura T, Kanno-Okada H, Hashino S, Tanaka S, Kamei K, Teshima T
    J Infect Chemother 24: 660-663, 2018.
  • Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment.
    Oya K, Fujii M, Taguchi S, Nishie W, Izumi K, Shimizu H
    Eur J Dermatol 28: 250-251, 2018.
  • aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability.
    Riddell M, Nakayama A, Hikita T, Mirzapourshafiyi F, Kawamura T, Pasha A, Li M, Masuzawa M, Looso M, Steinbacher T, Ebnet K, Potente M, Hirose T, Ohno S, Fleming I, Gattenlöhner S, Aung P, Phung T, Yamasaki O, Yanagi T, Umemura H, Nakayama M
    Nat. Commun. 9: 5357, 2018.
  • RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
    Saito N, Honma M, Shibuya T, Iinuma S, Igawa S, Kishibe M, Ishida-Yamamoto A
    J Dermatol Sci 91: 79-86, 2018.
  • Novel PSTPIP1 gene mutation in pyoderma gangrenosum, acne and suppurative hidradenitis syndrome.
    Saito N, Minami-Hori M, Nagahata H, Nozaki H, Iinuma S, Igawa S, Kanno K, Kishibe M, Kanazawa N, Ishida-Yamamoto A
    J Dermatol 45: e213-e214, 2018.
  • Intravenous IgG reduces pathogenic autoantibodies, serum IL-6 levels, and disease severity in experimental bullous pemphigoid models.
    Sasaoka T, Ujiie H, Nishie W, Iwata H, Ishikawa M, Higashino H, Natsuga K, Shinkuma S, Shimizu H
    J Invest Dermatol 138: 1260-1267, 2018.
  • A case of subepidermal autoimmune bullous disease with autoantibodies against 200 and 290-kDa antigens.
    Sawada M, Hida T, Ujiie H, Iwata H, Uhara H
    J Eur Acad Dermatol Venereol 32: e354-e355, 2018.
  • Inflammatory disseminated superficial porokeratosis successfully controlled with a combination of topical diclofenac gel and systemic etretinate.
    Shimizu S, Takashima Y, Hotta M, Ito E, Moriuchi R
    J Eur Acad Dermatol Venereol 32: e201-e202, 2018.
  • Successful treatment of hidradenitis suppurativa with rituximab for a patient with idiopathic carpotarsal osteolysis and chronic active antibody-mediated rejection.
    Takahashi K, Yanagi T, Kitamura S, Hata H, Imafuku K, Iwami D, Hotta K, Morita K, Shinohara N, Shimizu H
    J Dermatol 45: e116-e117, 2018.
  • Dipeptidyl Peptidase-4 Inhibitor-associated Bullous Pemphigoid: Recurrence with Epitope Spreading.
    Takama H, Yoshida M, Izumi K, Yanagishita T, Muto J, Ohshima Y, Nishie W, Shimizu H, Akiyama M, Watanabe D
    Acta Derm Venereol 98: 983-984, 2018.
  • Novel COL7A1 mutation in a family with bullous dermolysis of the newborn: Phenotypic variability associated with a COL7A1 mutation within the same family.
    Takashima S, Shinkuma S, Fujita Y, Natsuga K, Nomura T, Hida T, Ishikawa S, Nakamura H, Abe R, Shimizu H
    J Dermatol 45: e260-e261, 2018.
  • Compound heterozygous missense mutations p.Leu207Pro and p.Tyr544Cys in TGM1 cause a severe form of lamellar ichthyosis.
    Takeda M, Nomura T, Sugiyama T, Miyauchi T, Suzuki S, Fujita Y, Shimizu H
    J Dermatol 45: 1463-1467, 2018.
  • HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors.
    Ujiie H, Muramatsu K, Mushiroda T, Ozeki T, Miyoshi H, Iwata H, Nakamura A, Nomoto H, Cho KY, Sato N, Nishimura M, Ito T, Izumi K, Nishie W, Shimizu H
    J Invest Dermatol 138: 1201-1204, 2018.
  • Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
    Watanabe M, Natsuga K, Shinkuma S, Shimizu H
    J Dermatol 45: 515-521, 2018.
  • Sirolimus gel treatment vs placebo for facial angiofibromas in patients with tuberous sclerosis complex: a randomized clinical trial.
    Wataya-Kaneda M, Ohno Y, Fujita Y, Yokozeki H, Niizeki H, Ogai M, Fukai K, Nagai H, Yoshida Y, Hamada I, Hio T, Shimizu K, Murota H
    JAMA Dermatol 154: 781-788, 2018.
  • Appearance of antidesmocollin 1 autoantibodies leading to a vegetative lesion in a patient with pemphigus vulgaris.
    Yamaguchi Y, Shinkuma S, Ishii N, Takashima S, Natsuga K, Ujiie H, Iwata H, Nomura T, Fujita Y, Hamasaka A, Hamasaka K, Hashimoto T, Shimizu H
    Br J Dermatol 178: 294-295, 2018.
  • Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.
    Yamaguchi Y, Yanagi T, Sato K, Yoshimoto N, Hirata Y, Ujiie I, Nishimura M, Natsuga K, Shiiya C, Tsukinaga I, Shimizu H
    J Dermatol 45: 483-486, 2018.
  • Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma.
    Yanagi T, Kitamura S, Hata H
    Front Oncol 8: 79, 2018.
  • Loss of TRIM29 alters keratin distribution to promote cell invasion in squamous cell carcinoma.
    Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, Hatakeyama S
    Cancer Res 78: 6795-6806, 2018.
  • Bullous pemphigoid with the deposition of IgG2 but not IgG1, IgG3 nor IgG4 autoantibodies at the basement membrane zone.
    Yoshimoto N, Ujiie H, Zheng M, Iwata H, Kosumi H, Hata H, Shimizu H
    J Eur Acad Dermatol Venereol 32: e344-e346, 2018.
  • CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
    Yuki A, Shinkuma S, Hayashi R, Fujikawa H, Kato T, Homma E, Hamade Y, Onodera O, Matsuoka M, Shimizu H, Iwata H, Abe R
    J Am Acad Dermatol 79: 1039-1046, 2018.
  • A possible association between BP230-type bullous pemphigoid and dementia: a report of two cases in elderly patients.
    Zheng M, Ujiie H, Muramatsu K, Sato-Matsumura KC, Maeda T, Ujiie I, Iwata H, Izumi K, Nishie W, Shimizu H
    Br J Dermatol 178: 1449-1450, 2018.
  • Maculopapular drug eruption induced by linagliptin.
    Zheng M, Yoshimoto N, Muramatsu K, Ito T, Ujiie H, Shimizu H
    Australas J Dermatol 59: e287-e288, 2018.

日本語論文
Japanese Articles

  • 単純ヘルペスウイルスとサイトメガロウイルスの混合感染を生じた落葉状天疱瘡の1例.
    羽賀直哉, 保科大地, 古屋和彦, 高橋紘樹
    皮膚科の臨床 60: 597-601, 2018.
  • ELISPOT法で診断した陰茎結核疹の1例.
    羽賀直哉, 保科大地, 古屋和彦, 森裕二
    皮膚科の臨床 60: 271-274, 2018.
  • 頭皮に生じたWells症候群の1例.
    羽賀直哉, 保科大地, 古屋和彦, 鈴木昭
    皮膚科の臨床 60: 1762-1764, 2018.
  • 皮膚加齢における基底膜蛋白の生理学的意義の解明.
    夏賀健
    コスメトロジー研究報告 26: 94-97, 2018.
  • 仙骨・尾骨部褥瘡に骨髄炎を合併したHTLV-1関連脊髄症の1例.
    月永一郎, 野村友希子, 神田良太, 佐藤郁美, 長谷川あゆこ, 加藤智子
    日本褥瘡学会誌 20: 43-47, 2018.
  • 腎移植患者548例における、水痘帯状疱疹ウイルス感染症の検討.
    高島 有, 守内 玲, 白戸 貴, 和田 吉, 福澤 信, 原田 浩, 清水 聡
    西日本皮膚科 80: 280, 2018.
  • 免疫グロブリン大量静注が有効であった水疱性類天疱瘡の1例.
    真屋由佳, 守内玲寧, 高島有香, 清水聡子
    市立札幌病院医誌 78: 105-109, 2018.
  • 経皮的冠動脈インターベンション後に生じた放射線皮膚障害の4例.
    須貝達朗, 菊地一博, 安藤貴代, 足立功一, 飯田憲治, 神谷究, 坂井英世, 高平真, 中村裕之
    市立釧路総合病院医学雑誌 30: 75-80, 2018.
  • 足底に発生した複合型母斑の悪性黒色腫との鑑別点.
    前田拓哉, 秦洋郎, 柳輝希, 今福恵輔, 北村真也, 本間英里奈, 藤田靖幸, 清水宏
    日本皮膚科学会雑誌 128: 197-203, 2018.
  • ニボルマブによって生じた中毒性表皮壊死症の1例.
    辻脇真澄, 平田悠, 佐藤英嗣, 高村圭
    皮膚科の臨床 60: 15-18, 2018.
  • トラニラストが奏功したannular elastolytic giant cell granulomaの一例.
    藤村悠, 夏賀健, 伊東孝政, 青柳哲, 清水宏
    臨床皮膚科 72: 681-684, 2018.
  • 水疱性類天疱瘡の診断と治療.
    平田悠, 佐藤英嗣
    帯広厚生病院医誌 20: 7-12, 2018.
  • インフリキシマブ導入後4年目にHBVウイルス再活性化を生じた乾癬性関節炎の1例.
    保科大地, 羽賀直哉, 古屋和彦, 廣田ジョージョ, 伊藤圭
    皮膚科の臨床 60: 1573-1576, 2018.

総説
Reviews

  • Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
    Watanabe M, Natsuga K, Shinkuma S, Shimizu H
    J Dermatol 45: 515-521, 2018.
  • Novel therapeutic targets in cutaneous squamous cell carcinoma.
    Yanagi T, Kitamura S, Hata H
    Front Oncol 8: 79, 2018.
  • 【最近のトピックス2018】 DPP-4 阻害薬内服に伴う類天疱瘡と全長BP180 ELISA法.
    西江渉
    臨床皮膚科 72: 72-76, 2018.
  • 【最近のトピックス2018】 類天疱瘡診療ガイドラインについて.
    氏家英之
    臨床皮膚科 72: 121-124, 2018.
  • 【最近のトピックス2018】 Helicobacter cinaedi感染症と蜂窩織炎.
    清水聡子
    臨床皮膚科 72: 156-158, 2018.
  • 【最近のトピックス2018】 皮膚科医のための臨床トピックス マダニ咬症とダニ媒介性脳炎.
    守内玲寧
    臨床皮膚科 72: 159-161, 2018.
  • DPP-4阻害薬による類天疱瘡について.
    氏家英之
    日本医事新報 4901: 56, 2018.
  • 表皮水疱症に対する細胞療法の展開.
    藤田靖幸
    再生医療 17: 298-305, 2018.
  • 【心に残る症例】White fibrous papulosis of the neck.
    高島翔太, 藤田靖幸, 清水宏
    皮膚病診療 40: 47-50, 2018.
  • 【第34回臨床学術大会】(シンポジウム)あたらしい皮膚科学第3版を出版して:教科書改訂からみた皮膚科学10年の進歩.
    清水宏
    日本臨床皮膚科医会雑誌 35: 588-593, 2018.
  • 膿疱性乾癬における生物学的製剤の現状と問題点:顆粒球吸着療法の位置づけ.
    伊藤圭
    日本アフェレシス学会雑誌 37: 204-209, 2018.
  • DPP-4阻害薬と類天疱瘡の関係.
    氏家英之
    プラクティス 35: 577-578, 2018.
  • DPP-4阻害薬による類天疱瘡のリスク因子.
    氏家英之
    内分泌・糖尿病・代謝内科 47: 210-214, 2018.

著書・その他
Authors and others

  • 類天疱瘡群.
    氏家英之
    エキスパートから学ぶ 皮膚科診療パワーアップ. 東京: 中山書店. 2018. pp 216-220.
  • DPP-4阻害薬による水疱性類天疱瘡の臨床的特徴は?.
    氏家英之
    WHAT’S NEW in 皮膚科学 2018-2019. 東京: メディカルレビュー社. 2018. pp 98-99.
  • DPP-4阻害薬関連水疱性類天疱瘡.
    西江渉
    皮膚症状110症例でみる内科疾患. 東京: 日本医事新報社. 2018. pp 200-201.
  • (遺伝性・非症候性)掌蹠角化症.
    乃村俊史
    エキスパートから学ぶ 皮膚病診療パワーアップ. 東京: 中山書店. 2018. pp 305-309.
  • Sinusoidal hemangioma.
    北村真也
    血管腫・血管奇形臨床アトラス. 東京: 南江堂. 2018. pp 222-223.
  • 口腔乾燥症の診断と対応.
    鎌口真由美, 北川善政
    口腔外科のレベルアップ&ヒント. 東京: デンタルダイヤモンド社. 2018.
  • 線状IgA水疱性皮膚症.
    氏家英之, 林昌浩
    Visual Dermatology 17: 936-938, 2018.